Company Profile
Sera Prognostics Stock Price, News & Analysis
- Ticker:
- SERA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Sera Prognostics is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.84 USD (-0.54%)
Close
Last updated: June 23, 2026 at 00:00
72.05M USD
Market cap
Why the stock is moving
SERA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Sera Prognostics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sera Prognostics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Sera Prognostics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Sera Prognostics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
Source: Sera Prognostics
- 04
SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Source: Sera Prognostics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sera Prognostics (SERA)?
Sera Prognostics (SERA) most recently closed at 1.84 USD, a -0.54% move versus the previous session.
What is the market cap of Sera Prognostics (SERA)?
Sera Prognostics currently has a market capitalization of 72.05M USD on BioPharmSignal.
What does Sera Prognostics do?
Sera Prognostics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is SERA stock listed?
Sera Prognostics (SERA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Sera Prognostics is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Sera?
Sera Prognostics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Sera Prognostics targeting with Sera?
Sera Prognostics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Prognostics?
Sera Prognostics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.